Abstract CT290: Trial in progress: Evaluation of the safety, tolerability, whole-body distribution, radiation dosimetry and antitumor activity of 177Lu-NeoB in patients with advanced solid tumors expressing gastrin-releasing peptide receptor (GRPR)

已取消 20 由 Lilian 发布于 2025/10/21 14:30:15

DOI:10.1158/1538-7445.am2024-ct290
作者：Erik S. Mittra, Andrei Iagaru, A. V. D. van der Veldt, Luigi Aloj, Jeffrey Wong, L. Djaileb, Dhrubajyoti Pathak, Yongmin Liu, L. Solnes
文献类型：期刊论文
补充材料：只需要正文
管理员驳回:超时未应助，系统关闭。如求助信息不完整（标题、DOI、原文链接），可以补充后重新发布求助。

American Association for Cancer Research (AACR)

Abstract： Introduction: Many common cancers such as breast, lung, and prostate, plus several less common malignancies such as gastrointestinal stromal tumors (GIST) and glioblastoma (GBM) express or

应助信息

2025-10-21

Book学术机器人

2025/10/21 14:30:15 未找到该文献，机器人已退出，请等待人工下载

2025/10/21 14:30:15 Book学术AI机器人收到请求，开始寻找文献

2025/10/21 14:30:15 已向机器人发送请求

2025-10-21

Lilian 发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:知网汽油中芳烃含量测定法(气相色谱法)